Compounds > fructose-1,6-diphosphate

fructose-1,6-diphosphate and Sepsis

fructose-1,6-diphosphate has been researched along with Sepsis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Branchini, G; Catarina, AV; Da Costa, JC; De Oliveira, JR; Ferreira, F; Gonçalves, CA; Greggio, S; Leite, MC; Luft, C; Marques, EP; Nunes, FB; Rodrigues, L; Venturin, GT; Wartchow, K; Wyse, ATS1
de Oliveira, JR; de Oliveira, LM; Magrisso, AB; Munhoz, TP; Pires, MG; Roesler, R1
Alves Filho, JC; Nunes, FB; Rodrigues De Oliveira, J; Simões Pires, MG; Wächter, PH1
Alves Filho, JC; De Oliveira, JR; Graziottin, CM; Lunardelli, A; Nunes, FB; Pires, MG; Wächter, PH1
Muntané, J1
Bermudez, J; Boada, J; Calafell, R; Cuesta, E; Perales, JC; Roig, T1
Li, J; Shu, Z1

Other Studies

7 other study(ies) available for fructose-1,6-diphosphate and Sepsis

ArticleYear
Fructose-1,6-bisphosphate preserves glucose metabolism integrity and reduces reactive oxygen species in the brain during experimental sepsis.
    Brain research, 2018, 11-01, Volume: 1698

    Topics: Animals; Brain; Brain Diseases; Disease Models, Animal; Fluorodeoxyglucose F18; Fructose; Fructosediphosphates; Glucose; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Positron Emission Tomography Computed Tomography; Reactive Oxygen Species; Sepsis

2018
Fructose-1,6-bisphosphate inhibits in vitro and ex vivo platelet aggregation induced by ADP and ameliorates coagulation alterations in experimental sepsis in rats.
    Journal of thrombosis and thrombolysis, 2010, Volume: 29, Issue:4

    Topics: Adenosine Diphosphate; Animals; Blood Coagulation Disorders; Blood Platelets; Dose-Response Relationship, Drug; Fructosediphosphates; Humans; Immunologic Factors; Male; Partial Thromboplastin Time; Platelet Aggregation; Platelet Aggregation Inhibitors; Prothrombin Time; Rats; Rats, Wistar; Sepsis; Thrombocytopenia

2010
Physiopathological studies in septic rats and the use of fructose 1,6-bisphosphate as cellular protection.
    Critical care medicine, 2002, Volume: 30, Issue:9

    Topics: Animals; Fructosediphosphates; Male; Neuroprotective Agents; Rats; Rats, Wistar; Sepsis

2002
An assessment of fructose-1,6-bisphosphate as an antimicrobial and anti-inflammatory agent in sepsis.
    Pharmacological research, 2003, Volume: 47, Issue:1

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Drug Evaluation, Preclinical; Fructosediphosphates; Male; Rats; Rats, Wistar; Sepsis

2003
Multiple beneficial actions of fructose 1,6-biphosphate in sepsis-associated liver injury.
    Critical care medicine, 2006, Volume: 34, Issue:3

    Topics: Animals; Fructosediphosphates; Hepatocytes; Immunologic Factors; Kupffer Cells; Liver Failure, Acute; Macrophage Activation; Potassium Channels; Sepsis; Tumor Necrosis Factor-alpha

2006
Fructose 1,6-bisphosphate prevented endotoxemia, macrophage activation, and liver injury induced by D-galactosamine in rats.
    Critical care medicine, 2006, Volume: 34, Issue:3

    Topics: Analysis of Variance; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Fructosediphosphates; Galactosamine; Hepatocytes; Histamine Release; Immunologic Factors; Inflammation; Kupffer Cells; Liver Failure, Acute; Macrophage Activation; Potassium Channels; Rats; Rats, Sprague-Dawley; Sepsis; Tumor Necrosis Factor-alpha

2006
Fructose-1,6-diphosphate-added total parenteral nutrition in septic animals and stressed patients.
    Chinese medical journal, 2001, Volume: 114, Issue:11

    Topics: Adenosine Triphosphate; Adult; Aged; Animals; Critical Care; Dogs; Energy Metabolism; Fructosediphosphates; Humans; Middle Aged; Parenteral Nutrition, Total; Proteins; Sepsis; Stress, Physiological

2001